Farallon Capital Management »

Verastem shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $15M 2.0M 7.72

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding Verastem

Rtw Investments
Vanguard Group
Balyasny Asset Management
Polar Capital Holdings
BlackRock
State Street Corporation
Stonepine Capital Management
Foresite Capital Management VI
Armistice Capital
Farallon Capital Management
Rosalind Advisors
Logos Global Management
Goldman Sachs Group
Geode Capital Management
Millennium Management

View all funds holding Verastem